Autoantibodies involved in neuropsychiatric manifestations associated with Systemic Lupus Erythematosus

Journal of Neuroimmunology

Volumn 212, Issue 1-2, 2009, Pages 3-9

  Colasanti, Tania ^a   Delunardo, Federica ^a   Margutti, Paola ^a   Vacirca, Davide ^a   Piro, Ettore ^a   Siracusano, Alessandra ^a   Ortona, Elena ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Autoantibodies; Endothelium; Neurons; Neuropsychiatric manifestations; Pathogenesis; Systemic Lupus Erythematosus

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; CYCLOPHOSPHAMIDE; DNA ANTIBODY; ENDOTHELIAL CELL ANTIBODY; GANGLIOSIDE ANTIBODY; GLIAL FIBRILLARY ACIDIC PROTEIN ANTIBODY; HISTONE ANTIBODY; LUPUS ANTICOAGULANT ANTIBODY; MICROTUBULE ASSOCIATED PROTEIN 2 ANTIBODY; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEDD5 PROTEIN ANTIBODY; NEUROFILAMENT PROTEIN ANTIBODY; NEURONAL ANTIBODY; PHOSPHATIDYLETHANOLAMINE ANTIBODY; PHOSPHOLIPID ANTIBODY; RIBOSOMAL PROTEIN P ANTIBODY; RO ANTIBODY; SM ANTIBODY; TRIOSEPHOSPHATE ISOMERASE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; BLOOD ANALYSIS; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID ANALYSIS; COGNITIVE DEFECT; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EMOTIONAL DISORDER; HUMAN; IMMUNOPATHOGENESIS; MENTAL DISEASE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; ENDOTHELIAL CELLS; GANGLIOSIDES; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MENTAL DISORDERS; MICROTUBULE-ASSOCIATED PROTEINS; NEURONS; PHOSPHORIC MONOESTER HYDROLASES; RECEPTORS, N-METHYL-D-ASPARTATE; RIBOSOMES;

EID: 67649850389     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.05.003     Document Type: Review

References (89)

1. ACR ad hoc committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 42 (1999) 599-608
2. Afeltra A., Garzia P., Mitterhofer A.P., Vadacca M., Galluzzo S., Del Porto F., Finamore L., Pascucci S., Gasparini M., Laganà, B., Caccavo D., Ferri G.M., Amoroso A., and Francia A. Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. Neurology 61 (2003) 108-110
3. Ainiala H., Hietaharju A., Loukkola J., Peltola J., Korpela M., Metsanoja R., and Auvinen A. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum. 45 (2001) 419-423
4. Alosachie I.J., Terryberry J.W., Mevorach D., Chapman Y., Lorber M., Torre D., Youinou P., Peter J.B., and Shoenfeld Y. Central nervous system (CNS) involvement in SLE. The diagnostic role of antibodies to neuronal antigens. Clin. Rev. Allergy Immunol. 16 (1998) 275-284
5. Arinuma Y., Yanagida T., and Hirohata S. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 58 (2008) 1130-1135
6. Armitage J.D., Homer-Vanniasinkam S., and Lindsey N.J. The role of endothelial cell reactive antibodies in peripheral vascular disease. Autoimmun. Rev. 3 (2004) 39-44
7. Avinoach I., Amital-Teplizki H., Kuperman O., Isenberg D.A., and Shoenfeld Y. Characteristics of antineuronal antibodies in systemic lupus erythematosus patients with and without central nervous system involvement: the role of mycobacterial cross-reacting antigens. Isr. J. Med. Sci. 26 (1990) 367-373
8. Ben-Chetrit E. The molecular basis of the SSA/Ro antigens and the clinical significance of their autoantibodies. Br. J. Rheumatol. 32 (1993) 396-402
9. Bluestein H.G., Williams G.W., and Steinberg A.D. Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. Am. J. Med. 70 (1981) 240-246
10. Bonfa E., and Elkon K.B. Clinical and serologic associations of the antiribosomal P protein antibody. Arthritis Rheum. 29 (1986) 981-985
11. Bonfa E., Golombek S.J., Kaufman L.D., Skelly S., Weissbach H., Brot N., and Elkon K.B. Association between lupus psychosis and anti-ribosomal P protein Abs. N. Engl. J. Med. 317 (1987) 265-271
12. Borchers A.T., Aoki C.A., Naguwa S.M., Keen C.L., Shoenfeld Y., and Gershwin M.E. Neuropsychiatric features of systemic lupus erythematosus. Autoimmun. Rev. 4 (2005) 329-344
13. Bresnihan B., Oliver M., Williams B., and Hughes G.R. An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus. Arthritis Rheum. 22 (1979) 313-320
14. Chapman J., Cohen-Armon M., Shoenfeld Y., and Korczyn A.D. Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes. Lupus 8 (1999) 127-133
15. Chen Y., Wu F., Hou L., Ma S., and He X. Antiganglioside antibodies in cerebrospinal fluid of children with neuropsychiatric lupus erythematosus. Chin. Med. J. 110 (1997) 594-597
16. Conti F., Alessandri C., Bompane D., Bombardieri M., Spinelli F.R., Rusconi A.C., and Valesini G. Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies. Arthritis Res. Ther. 6 (2004) R366-R372
17. Danon Y.L., and Garty B.Z. Autoantibodies to neuroblastoma cell surface antigens in neuropsychiatric lupus. Neuropediatrics 17 (1986) 23-27
18. D'Cruz D.P., Houssiau F.A., Ramirez G., Baguley Y., McCutcheon J., Vianna J., Haga H.J., Swana G.T., Khamashta M.A., Taylor J.C., Davies D.R., and Hughes G.R.V. Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis. Clin. Exp. Immunol. 85 (1991) 254-261
19. DeGiorgio L.A., Konstantinov K.N., Lee S.C., Hardin J.A., Volpe B.T., and Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med. 7 (2001) 1189-1193
20. Denburg J.A., Carbotte R.M., and Denburg S.D. Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology 37 (1987) 464-467
21. Denburg S.D., Carbotte R.M., Ginsberg J.S., and Denburg J.A. The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J. Int. Neuropsychol. Soc. 3 (1997) 377-386
22. Diamond B., and Volpe B.T. Antibodies and brain disease: a convergence of immunology and physiology. PLoS Med. 3 (2006) e498
23. Diamond B., Kowal C., Huerta P.T., Aranow C., Mackay M., DeGiorgio L.A., Lee J., Triantafyllopoulou A., Cohen-Solal J., and Volpe B.T. Immunity and acquired alterations in cognition and emotion: lessons from SLE. Adv. Immunol. 89 (2006) 289-320
24. Ebert T., Chapman J., and Shoenfeld Y. Anti-ribosomal P protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality?. Lupus 14 (2005) 571-575
25. Elkon K.B., Parnassa A.P., and Foster C.L. Lupus autoAbs target ribosomal P proteins. J. Exp. Med. 162 (1985) 459-471
26. Emmi L., Bramati M., De Cristofaro M.T., Mascalchi M., Dal Pozzo G., Marconi G.P., Massai G., and Passaleva A. MRI and SPECT investigations of the CNS in SLE patients. Clin. Exp. Rheumatol. 11 (1993) 13-20
27. Fields R.A., Sibbitt W.L., Toubbeh H., and Bankhurst A.D. Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies. Ann. Rheum. Dis. 49 (1990) 114-117
28. Galeazzi M., Annunziata P., Sebastiani G.D., Bellisai F., Campanella V., Ferrara G.B., Font J., Houssiau F., Passiu G., De Ramon Garrido E., Fernandez-Nebro A., Bracci L., Scorza R., Puddu P., Jedryka-Goral A., Smolen J., Tincani A., Carcassi C., Morozzi G., and Marcolongo R. Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological, and HLA class II gene associations. J. Rheumatol. 27 (2000) 135-141
29. Gaynor B., Putterman C., Valadon P., Spatz L., Scharff M.D., and Diamond B. Peptide inhibition of glomerular deposition of an anti-DNA antibody. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 1955-1960
30. Georgescu L., Mevorach D., Arnett F.C., Reveille J.D., and Elkon K.B. Anti-P Abs and neuropsychiatric lupus erythematosus. Ann. N.Y. Acad. Sci. 823 (1997) 263-269
31. Greenwood D.L., Gitlits V.M., Alderuccio F., Sentry J.W., and Toh B.H. AutoAbs in neuropsychiatric lupus. Autoimmunity 35 (2002) 79-86
32. Hanly J.G., Behmann S., Denburg S.D., Carbotte R.M., and Denburg J.A. The association between sequential changes in serum antineuronal antibodies and neuropsychiatric systemic lupus erythematosus. Postgrad. Med. J. 65 (1989) 622-627
33. Hanly J.G., Robichaud J., and Fisk J.D. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus. J. Rheumatol. 33 (2006) 1553-1558
34. Hanly J.G., Urowitz M.B., Siannis F., Farewell V., Gordon C., Bae S.C., Isenberg D., Dooley M.A., Clarke A., Bernatsky S., Gladman D., Fortin P.R., Manzi S., Steinsson K., Bruce I.N., Ginzler E., Aranow C., Wallace D.J., Ramsey-Goldman R., van Vollenhoven R., Sturfelt G., Nived O., Sanchez-Guerrero J., Alarcón G.S., Petri M., Khamashta M., Zoma A., Font J., Kalunian K., Douglas J., Qi Q., Thompson K., and Merrill J.T. Systemic lupus international collaborating clinics autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum. 58 (2008) 843-853
35. Hanson V.G., Horowitz M., Rosenbluth D., Spiera H., and Puszkin S. Systemic lupus erythematosus patients with central nervous system involvement show autoantibodies to a 50 kD neuronal membrane protein. J. Exp. Med. 176 (1992) 565-573
36. Huerta P.T., Kowal C., DeGiorgio L.A., Volpe B.T., and Diamond B. Immunity and behavior: antibodies alter emotion. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 678-683
37. Jurencák R., Fritzler M., Tyrrell P., Hiraki L., Benseler S., and Silverman E. Autoantibodies in pediatric systemic lupus erythematosus: ethnic grouping, cluster analysis, and clinical correlations. J. Rheumatol. 36 (2009) 416-421
38. Kaposi M. Neue beitrage zur kenntnis des lupus erythematosus. Arch. Dermatol. Syph. 4 (1872) 36-79
39. Karassa F.B., Magliano M., and Isenberg D.A. Suicide attempts in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 62 (2003) 58-60
40. Karmochkine M., Berard M., Piette J.C., Cacoub P., Aillaud M.F., Harle J.R., Godeau P., Boffa M.C., and Harlet J.R. Antiphosphatidylethanolamine antibodies in systemic lupus erythematosus. Lupus 2 (1993) 157-160
41. Katzav A., Ben-Ziv T., Chapman J., Blank M., Reichlin M., and Shoenfeld Y. Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS-SLE (depression). J. Autoimmun. 31 (2008) 393-398
42. Kiss E., and Shoenfeld Y. Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus?. Clin. Rev. Allergy Immunol. 32 (2007) 37-46
43. Koffler D., Miller T.E., and Lahita R.G. Studies on the specificity and clinical correlation of antiribosomal Abs in systemic lupus erythematosus sera. Arthritis Rheum. 22 (1979) 463-470
44. Koscec M., Koren E., Wolfson-Reichlin M., Fugate R.D., Trieu E., Targoff I.N., and Reichlin M. Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture. J. Immunol. 159 (1997) 2033-2041
45. Kowal C., DeGiorgio L.A., Nakaoka T., Hetherington H., Huerta P.T., Diamond B., and Volpe B.T. Cognition and immunity; antibody impairs memory. Immunity 21 (2004) 179-188
46. Kowal C., DeGiorgio L.A., Lee J.Y., Edgar M.A., Huerta P.T., Volpe B.T., and Diamond B. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 19,854-19,859
47. Kozora E., Ellison M.C., and West S. Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery. Arthritis Rheum. 55 (2006) 628-635
48. Lai N.S., and Lan J.L. Evaluation of cerebrospinal anticardiolipin antibodies in lupus patients with neuropsychiatric manifestations. Lupus 9 (2000) 353-357
49. Lee J.Y., Huerta P.T., Zhang J., Kowal C., Bertini E., Volpe B.T., and Diamond B. Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus. Nat. Med. 15 (2009) 91-96
50. Love P.E., and Santoro S.A. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann. Intern. Med. 112 (1990) 682-698
51. Margutti P., Sorice M., Conti F., Delunardo F., Racaniello M., Alessandri C., Siracusano A., Riganò R., Profumo E., Valesini G., and Ortona E. Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations. Arthritis Res. Ther. 7 (2005) R896-R903
52. Martinez X., Tintore M., Montalban J., Ordi J., Vilardell M., and Codina A. Antibodies against angliosides in patients with SLE and neurological manifestations. Lupus 1 (1992) 299-302
53. Martinez-Cordero E., Rivera Garcia B.E., and Aguilar Leon D.E. Anticardiolipin antibodies in serum and cerebrospinal fluid from patients with systemic lupus erythematosus. J. Investig. Allergol. Clin. Immunol. 7 (1997) 596-601
54. Matus S., Burgos P.V., Bravo-Zehnder M., Kraft R., Porras O.H., Farías P., Barros L.F., Torrealba F., Massardo L., Jacobelli S., and González A. Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis. J. Exp. Med. 204 (2007) 3221-3234
55. McLaurin E.Y., Holliday S.L., Williams P., and Brey R.L. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology 64 (2005) 297-303
56. Meroni P.L., Tincani A., Sepp N., Raschi E., Testoni C., Corsini E., Cavazzana I., Pellegrini S., and Salmaggi A. Endothelium and the brain in CNS lupus. Lupus 129 (2003) 19-28
57. Mevorach D., Raz E., and Steiner I. Evidence for intrathecal synthesis of autoantibodies in systemic lupus erythematosus with neurological involvement. Lupus 3 (1994) 117-121
58. Migliorini P., Baldini C., Rocchi V., and Bombardieri S. Anti-Sm and anti-RNP antibodies. Autoimmunity 38 (2005) 47-54
59. Mikdashi J., and Handwerger B. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Rheumatology (Oxford) 43 (2004) 1555-1560
60. Mok C.C., Lau C.S., and Wong R.W. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J. Rheumatol. 28 (2001) 766-771
61. Morris R.G., Anderson E., Lynch G.S., and Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-d-aspartate receptor antagonist, AP5. Nature 319 (1986) 774-776
62. Papa N.D., Raschi E., Moroni G., Panzeri P., Borghi M.O., Ponticelli C., Tincani A., Balestrieri G., and Meroni P.L. Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-inflammatory phenotype in vitro. Lupus 8 (1999) 423-429
63. Pereira R.M., Yoshinari N.H., De Oliveira R.M., and Cossermelli W. Antiganglioside antibodies in patients with neuropsychiatric systemic lupus erythematosus. Lupus 1 (1992) 175-179
64. Rahman A., and Hiepe F. Anti-DNA antibodies-overview of assays and clinical correlations. Lupus 11 (2002) 770-773
65. Ravelli A., Caporali R., Di Fuccia G., Zonta L., Montecucco C., and Martini A. Anticardiolipin antibodies in pediatric systemic lupus erythematosus. Arch. Pediatr. Adolesc. Med. 148 (1994) 398-402
66. Reichlin M. Cellular dysfunction induced by penetration of autoantibodies into living cells: cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P proteins. J. Autoimmun. 11 (1998) 557-561
67. Reichlin M. Ribosomal P Abs and CNS lupus. Lupus 12 (2003) 916-918
68. Reichlin M., and Wolfson-Reichlin M. Evidence for the participation of anti-ribosomal P Abs in lupus nephritis. Arthritis Rheum. 42 (1999) 2728-2729
69. Reiff A., Miller J., Shaham B., Bernstein B., and Szer I.S. Childhood central nervous system lupus; longitudinal assessment using single photon emission computed tomography. J. Rheumatol. 24 (1997) 2461-2465
70. Robbins M.L., Kornguth S.E., Bell C.L., Kalinke T., England D., Turski P., and Graziano F.M. Antineurofilament antibody evaluation in neuropsychiatric systemic lupus erythematosus. Combination with anticardiolipin antibody assay and magnetic resonance imaging. Arthritis Rheum. 31 (1988) 623-631
71. Sanna G., Piga M., Terryberry J.W., Peltz M.T., Giagheddu S., Satta L., Ahmed A., Cauli A., Montaldo C., Passiu G., Peter J.B., Shoenfeld Y., and Mathieu A. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus 9 (2000) 573-583
72. Sanna G., Bertolaccini M.L., Cuadrado M.J., Laing H., Khamashta M.A., Mathieu A., and Hughes G.R. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J. Rheumatol. 30 (2003) 985-992
73. Sasajima T., Watanabe H., Sato S., Sato Y., and Ohira H. Anti-triosephosphate isomerase antibodies in cerebrospinal fluid are associated with neuropsychiatric lupus. J. Neuroimmunol. 181 (2006) 150-156
74. Seaman D.E., Londino Jr. A.V., Kwoh C.K., Medsger Jr. T.A., and Manzi S. Antiphospholipid antibodies in pediatric systemic lupus erythematosus. Pediatrics 96 (1995) 1040-1045
75. Sharma A., Isenberg D., and Diamond B. Studies of human polyclonal and monoclonal antibodies binding to lupus autoantigens and cross-reactive antigens. Rheumatology (Oxford) 42 (2003) 453-463
76. Shimojima Y., Matsuda M., Gono T., Ishii W., and Ikeda S. Relationship between clinical factors and neuropsychiatric manifestations in systemic lupus erythematosus. Clin. Rheumatol. 24 (2005) 469-475
77. Singh R.R., Malaviya A.N., Kailash S., and Varghese T. Clinical significance of anti-Sm antibody in systemic lupus erythematosus & related disorders. Indian J. Med. Res. 94 (1991) 206-210
78. Song J., Park Y.B., Lee W.K., Lee K.H., and Lee S.K. Clinical association of anti-endothelial cell antibodies in patients with systemic lupus erythematosus. Rheumatol. Int. 20 (2000) 1-7
79. Sun K.H., Liu W.T., Tsai C.Y., Liao T.S., Lin W.M., and Yu C.L. Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum. Ann. Rheum. Dis. 51 (1992) 707-712
80. Sun X.Y., Shi J., Han L., Su Y., and Li Z.G. Anti-histones antibodies in systemic lupus erythematosus: prevalence and frequency in neuropsychiatric lupus. J. Clin. Lab. Anal. 22 (2008) 271-277
81. Tin S.K., Xu Q., Thumboo J., Lee L.Y., Tse C., and Fong K.Y. Novel brain reactive autoantibodies: prevalence in systemic lupus erythematosus and association with psychoses and seizures. J. Neuroimmunol. 169 (2005) 153-160
82. Toubi E., and Shoenfeld Y. Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmun. Rev. 6 (2007) 119-125
83. Trysberg E., Nylen K., Rosengren L.E., and Tarkowski A. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. Arthritis Rheum. 48 (2003) 2881-2887
84. Watanabe H., Seino T., and Sato Y. Antibodies to triosephosphate isomerase in patients with neuropsychiatric lupus. Biochem. Biophys. Res. Commun. 321 (2004) 949-953
85. Williams Jr. R.C., Sugiura K., and Tan E.M. Antibodies to microtubule-associated protein 2 in patients with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 50 (2004) 1239-1247
86. Winfield J.B., Brunner C.M., and Koffler D. Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction. Arthritis Rheum. 21 (1978) 289-294
87. Yoshio T., Hirata D., Onda K., Nara H., and Minota S. Anti-ribosomal P protein Abs in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus. J. Rheumatol. 32 (2005) 34-39
88. Zandman-Goddard G., Chapman J., and Shoenfeld Y. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin. Arthritis Rheum. 36 (2007) 297-315
89. Ziporen L., Polak-Charcon S., Korczyn D.A., Goldberg I., Afek A., Kopolovic J., Chapman J., and Shoenfeld Y. Neurological dysfunction associated with antiphospholipid syndrome: histopathological brain findings of thrombotic changes in a mouse model. Clin. Dev. Immunol. 11 (2004) 67-75